HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luisa Vigevani Selected Research

U2 Small Nuclear Ribonucleoprotein

12/2017Molecular basis of differential 3' splice site sensitivity to anti-tumor drugs targeting U2 snRNP.
1/2017Sudemycin K: A Synthetic Antitumor Splicing Inhibitor Variant with Improved Activity and Versatile Chemistry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luisa Vigevani Research Topics

Disease

3Neoplasms (Cancer)
12/2017 - 11/2012
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2012
1Influenza in Birds (Avian Flu)
06/2011

Drug/Important Bio-Agent (IBA)

2U2 Small Nuclear RibonucleoproteinIBA
12/2017 - 01/2017
2RNA Splicing FactorsIBA
01/2017 - 11/2012
1RNA Splice SitesIBA
12/2017
1spliceostatin AIBA
12/2017
1Antineoplastic Agents (Antineoplastics)IBA
01/2017
1RNA Precursors (Precursor, mRNA)IBA
01/2017
1Small Nuclear Ribonucleoproteins (snRNP)IBA
01/2017
1AmidesIBA
01/2017
1Protein Subunits (Protein Subunit)IBA
01/2017
1sudemycin KIBA
01/2017
1Proteins (Proteins, Gene)FDA Link
11/2012
1AntigensIBA
06/2011
1Serum-Free Culture MediaIBA
06/2011

Therapy/Procedure

1Therapeutics
11/2012